probatix
Application · Insurance & Health Funds

Prevention diagnostics for your insured members – digital and scalable.

Probatix enables health funds and insurers to run modern diagnostics programmes – from early detection to data-driven care management. Fully under your brand, seamlessly integrated, ready to deploy immediately.

Request ROI calculation Scope of service

References – selected partners

IKK SüdwestMOBIL Krankenkasseenergie BKKBKK Linde
KKH
Scope of service

Everything from a single source –
without operational overhead

You define your prevention programme. Probatix takes care of the entire operational infrastructure behind it – from kit production to digital result delivery.

Full platform description

White-Label Test Kits

Individually branded kits with your logo

Accredited Laboratory Analysis

ISO 15189 accredited, EU-wide

Fulfillment & Shipping

Automated, EU-wide, with tracking

Digital Result Delivery

Via API, portal, or patient app

Partner Portal

Order management for your team

GDPR Compliance

Data processing exclusively within the EU

Available tests

Screening offerings for every need

Choose from established panels or have custom tests configured – matched to your insured population structure and care strategy.

Cardiovascular Risk

Lipids, Lp(a), hsCRP

Diabetes Early Detection

HbA1c, Fasting Glucose

Colorectal Cancer Screening

Faecal Occult Blood Test (FOB)

PSA Cancer Screening

PSA, free PSA – prostate cancer prevention

Thyroid

TSH, fT3, fT4

Sexual Health

STI screening, Chlamydia, HIV, Syphilis

HPV Risk Test

Self-swab, laboratory analysis

Custom Panels

Tailored to your insured population structure

Reimbursement & Funding

Statutory framework under SGB V

Probatix-supported diagnostics programmes can be funded and implemented within various care models under SGB V.

§ 140a SGB V

Selective Contracts – Special Care

Direct contracts between health funds and service providers outside the collective agreement. Enables structured diagnostics programmes with clearly defined service modules and billing logic.

§ 25 SGB V

Low-Barrier Access to Health Prevention

Statutory mandate to promote early-detection examinations. Home testing lowers access barriers and increases uptake rates – measurably and documentably.

§ 20a SGB V

Member Retention & Health Literacy

Promoting measures to strengthen health competence. Diagnostics programmes create genuine added value for insured members and differentiate your offering in a competitive market.

§ 20b SGB V

Optimising Care Steering

Data-driven care management through valid biomarker data. Early detection reduces costly late-stage consequences and enables targeted interventions at the right moment.

Process

From concept to live operation

01

Configuration

Define panels, branding, and shipping options together – typically within a few days. No lengthy approval processes.

02

Invitation & Activation

Insured members order and activate themselves via link, QR code, or app – the kit arrives directly at home. No practice visit, no appointment needed.

03

Result & Routing

Results are delivered digitally – to your platform and directly to the insured member. Optional: flexible routing to telemedicine, contracted physicians (116/117), or other care providers according to your rules.

Economic analysis

Request an ROI calculation for your care concept

Based on your insured population structure, we prepare an individual economic analysis – including cost estimates, scaling scenarios, and reimbursement options under SGB V.

Request ROI calculation or schedule a demo call
FAQ

Frequently asked questions

Which SGB V sections can a Probatix programme be financed through?
The most common routes: §140a (special care / selective contracts), §25 (early detection), §20a (health promotion), §20b (treatment steering). Which section applies depends on the care objective. More in the article "Financing prevention".

What is the participation rate among insured members with home testing?
Significantly higher than with clinic-based procedures. The Dutch population-wide study on colorectal cancer screening consistently shows over 70% participation in the postally delivered FIT/iFOBT — compared with 22% for colonoscopy. The lever is highly measurable and transferable to other prevention indications.

Do we receive an economic analysis?
Yes. Based on the structure of your insured population we prepare an individual model — with cost estimates per module, scaling scenarios and suitable financing routes. It does not replace legal advice, but complements it as an operational basis for decisions.

Are the results GDPR-compliant and EU-hosted?
Yes. Data is processed exclusively in the EU, with no transfer to third countries without a legal basis. We provide a data processing agreement (DPA) and technical-organisational measures (TOMs); the system runs to ISO 27001.

Who routes out-of-range results to contracted physicians?
Via webhook and defined thresholds, out-of-range results can be handed over automatically to connected practices or medical-centre structures (including under §116b/117). You can either use our existing contracted-physician connection or plug in your own.